When is self-optimization sensible and when do I need help?

Lifestyle and substance optimization fit mild to moderate mood swings, stress symptoms and exhaustion within normal life burden. Professional help is indicated for: symptoms over 2 weeks with significant impact on daily life, suicidal thoughts, hopelessness, severe sleep disorders despite hygiene, substance abuse, traumatic history, acute anxiety with panic attacks. Here no plant and no tracker is a substitute for a psychotherapist or psychiatrist.

Saffron — does it really work for mood?

Yes, with surprisingly solid evidence. Several meta-analyses (Lopresti, Hausenblas) show for saffron extract (30 mg/day, standardized to crocin and safranal) antidepressant effects comparable to low-dose SSRIs in mild to moderate depressive symptoms. Onset 6–8 weeks. Mechanism: serotonin and dopamine modulation, anti-inflammatory, antioxidative. Trade-offs: relatively expensive, mild gastric irritation possible. For severe symptoms: not an alternative to professional treatment.

SAMe (S-adenosylmethionine) — when is it sensible?

SAMe is a body-own methyl donor. Multiple RCTs show antidepressant effects at 400–1600 mg/day, onset faster than SSRIs (1–2 weeks). Particularly effective in subgroup with methylation issues (MTHFR polymorphisms). Trade-offs: expensive (40–80 €/month), frequent gastric irritation, can trigger manic episodes in bipolar disposition. Combination with SSRIs only under medical guidance due to serotonin syndrome risk.

Vagus nerve activation — what works evidence-based?

Breathing techniques are the most accessible vagus lever with the best evidence. Slow breathing (4–6 breaths/min, inhale 4 s, exhale 6–8 s) for 5–20 min measurably raises HRV and parasympathetic activity. Cold facial exposure (diving reflex) acutely dampens panic. Singing, humming, gargling also activate the vagus. Transcutaneous vagus stimulation (tVNS devices) has limited clinical data; in home settings evidence is thin. Meditation, yoga and HRV biofeedback all work via the same pathway.

5-HTP — for sleep and mood?

5-HTP is a precursor to serotonin and can theoretically raise both pools. Studies on depression: smaller RCTs show effects comparable to SSRIs, but methodological weaknesses. Effect on sleep onset: documented at 100–300 mg before bed. Important cautions: serotonin syndrome with SSRIs, MAO inhibitors or triptans — separate strictly in time or avoid. Long-term dosing could alter amino acid balance; not longer than 3–6 months without break.

Meditation — how much per day makes a difference?

Robust meta-analysis (Pascoe et al., n=44 studies) shows: 20 min/day for 8 weeks reproducibly leads to reduced cortisol values (−25 %), lower subjective stress scores and better mood. Even 10 min/day has measurable effects when consistent. Form less crucial than consistency: mindfulness, loving-kindness, transcendental meditation have similar effects. A pure app-based solution (Calm, Headspace) is sufficient for beginners — a longer retreat or teacher accelerates the learning process.

St. John's Wort — hype or real substance?

For mild to moderate depressive symptoms several large meta-analyses with efficacy comparable to SSRIs (Cochrane review). Dose: 600–900 mg/day, standardized extract (e.g., WS 5570). Trade-offs are substantial: strong inducer of cytochrome-P450 enzymes — interacts with oral contraceptives (failure risk!), anticoagulants, immunosuppressants, antiretrovirals, many other drugs. With any concurrent medication: mandatory pharmacist or physician consultation. In severe cases no replacement for modern treatment.

EMDR and trauma therapy — where's the boundary to self-optimization?

EMDR (Eye Movement Desensitization and Reprocessing) is a trauma-specific psychotherapy method with strong evidence for PTSD and traumatic experiences. It belongs in the hands of qualified therapists — self-EMDR apps and YouTube tutorials are not recommended as evidence-based and can destabilize traumatized material. Anyone suspecting trauma history (childhood trauma, accidents, assaults) should take the step to therapy — no supplement resolves these themes.

All worlds

TEN WORLDS · 09 · MENTAL

Mental

This world shows evidence-based levers for mood, resilience, anti-stress effects — for normal everyday stresses. It is not a substitute for psychotherapy or medical treatment when those are indicated.

Reviewed May 14, 2026

What this world covers

Mental health biohacking is the world where the boundary between optimization and treatment matters most. This world covers evidence-based levers for mild to moderate mood and stress symptoms in daily life: meditation and mindfulness, breathwork and vagus nerve activation, adaptogens and phytotherapeutics (saffron, St. John's Wort), classical amino acid precursors (5-HTP, L-tryptophan, SAMe), sound and cold interventions for acute modulation.

What does NOT belong in this world: the treatment of moderate to severe depression, anxiety disorders with functional impairment, PTSD, bipolar illness, addiction, acute suicidality. These domains belong in the hands of qualified physicians and therapists. Self-optimization can complement here — but cannot replace.

Why the order matters

In the mental domain, the temptation is great to intervene with substances — saffron, SAMe, 5-HTP. But the biggest effects come from non-substance levers: sleep, exercise, social bonds, meaning, daily structure, meditation. Anyone neglecting these foundations cannot make up with a pill what their lifestyle has lost.

Pragmatic order:

Sleep (World 08): chronic sleep restriction is one of the most robust mood killers
Exercise: 150 min moderate cardio + 2× strength per week affects depressive symptoms comparably to antidepressants (Cochrane review)
Social bonds: loneliness is physiologically inflammatory and comparable to 15 cigarettes/day in mortality effect
Daily structure and routine: consistent sleep-wake times, regular meals, daylight in the morning
Meditation / mindfulness: 20 min/day with measurable effect on cortisol and anxiety after 8 weeks
Only then: phytotherapeutics and adaptogens (saffron, Rhodiola, ashwagandha)
For clinical indication: medical guidance — not solvable in the stack-builder

The most important levers

Meditation and mindfulness

The most robust non-medication lever with outcome data. Pascoe et al. (meta-analysis, n=44 studies) shows:

Cortisol AUC: −25 % after 8 weeks
Subjective stress symptoms: significant reduction
Anxiolysis comparable to benzodiazepine effect sizes
Structural changes (insula, hippocampus) measurable from 8 weeks

Protocol for beginners:

10 min/day for 8 weeks, then 20 min/day
Form (mindfulness, loving-kindness, TM, breath-based): secondary to consistency
App-based (Calm, Headspace, Waking Up) sufficient for beginners

Saffron (crocin/safranal)

Phytotherapeutic with surprisingly solid clinical evidence for mild to moderate depressive symptoms.

Dosing:

30 mg/day, standardized extract
Onset 6–8 weeks
Effect size: comparable to low-dose SSRIs in head-to-head studies

Mechanism: serotonin reuptake inhibition, anti-inflammatory and antioxidant effects. Very good safety profile, mild GI complaints possible.

SAMe (S-adenosylmethionine)

Body-own methyl donor with antidepressant action in RCTs. Particularly effective in subgroup with MTHFR polymorphisms.

Dosing:

Start at 400 mg/day, can increase to 1600 mg
Onset 1–2 weeks (faster than SSRIs)
Take on empty stomach, gastric acid raises bioavailability

Cautions: can trigger mania in bipolar disposition. Serotonin syndrome risk with SSRIs — not without medical guidance. Expensive (40–80 €/month).

Vagus nerve activation

Daily intervention for stress resilience, evidence-based in multiple mechanisms.

Methods:

Slow breathing: 4–6 breaths/min, 5–20 min — raises HRV, lowers sympathetic activity
Cold facial exposure: activates diving reflex, dampens acute panic
Singing / humming / gargling: stimulates via vagus branch in larynx
Meditation, yoga, HRV biofeedback: all via vagus pathway

Effect acutely measurable (HRV rise), chronic consolidation through routine.

How we rate evidence

Mental health outcomes are methodologically especially delicate — placebo effects high (40–60 % in many antidepressant trials), scales vary in sensitivity. We weight:

Meta-analyses with validated scales (Hamilton Depression Rating Scale, HAM-A, PHQ-9, GAD-7)
RCTs with active control (not just placebo) and clinically relevant endpoints
Effect duration and sustainability (acute effects vs. long-term stability)
Safety and interaction profile with common psychopharmaceuticals

Important: we explicitly separate studies on clinical depression, subclinical symptoms and healthy adults with everyday stress. Effects don't transfer.

Most common effects and interactions

Mental substances interact strongly with prescription psychopharmaceuticals:

SSRIs + 5-HTP / L-tryptophan / SAMe / saffron: serotonin syndrome risk, contraindicated without medical guidance
MAO inhibitors + tyramine-containing foods + 5-HTP / L-tyrosine: hypertensive crisis
St. John's Wort + cytochrome substrates: numerous interactions (contraceptives, anticoagulants, immunosuppressants, antiretrovirals)
Lithium + saffron / SAMe: caution, medical accompaniment
Alcohol + all mental substances: effects and risks significantly modified

What does NOT belong in this world

Clinical depression, anxiety disorder, PTSD, bipolar illness: medical and psychotherapeutic domain
Acute suicidality: emergency, no self-optimization here
Addiction and dependency: specialized therapy
Microdosing psychedelics: legally and evidence-wise a separate discussion, not covered in this world
Sleep substances: → World 08 (Sleep)
Classical stress adaptogens for performance → World 05 (Cognition)

Vitamin D, omega-3, B vitamins are mentally relevant but belong primarily in World 01 (Foundation) — status correction is the base for any mental optimization.

How Biohacking AI operationalizes this

This world works with elevated caution and clear escalation:

The Mood Tracker documents daily mood and stress markers, correlates with lifestyle variables (sleep, training, meals, social contacts) and surfaces patterns.
The Studies database separates strictly by symptom severity — what works for mild depressive mood is not automatically sufficient for clinical depression.
The Forum has strict moderation — no self-diagnosis, no recommendations for prescription substances outside medical indication, clear triage to professional help on warning signs.
The Coach works in escalation tiers: lifestyle and methods first, then evidence-based substances, and proactively triggers the question "do you need a human right now, not an algorithm" when warning signs appear.

The goal is not "better mood through more trackers." The goal is: build resilience in daily life, with the evidence-based levers — and honestly recognize when the next step is a therapist, not a supplement.

If you are in crisis: in the US, the 988 Suicide & Crisis Lifeline is reachable at 988. In the UK, Samaritans at 116 123. In Germany, Telefonseelsorge at 0800 111 0 111 or 0800 111 0 222. All anonymous, free, 24/7.

How we operationalize it

The platform for this world

Mood tracker with pattern detection

Log daily mood markers, sleep, training and stressors — the AI finds patterns you overlook yourself and tells you which variables correlate most strongly with your mood.

Studies database for mental health

For every substance and method you see RCTs on depressive, anxious or stress symptoms — with clear distinction between mild, moderate and severe symptoms.

Forum with professional moderation

In the mental forum you exchange notes with others — moderated by therapeutically experienced advisors, with clear pointers when professional help is needed.

Coach with escalation tiers

The coach works in tiers: lifestyle and methods first, then evidence-based substances — and clearly triggers when there are signs of symptoms needing medical care.

Substances & topics

What is curated in Mental

10 topics under continuous study monitoring. Each links to its full evidence overview.

5-HTP

Serotonin-Vorläufer, Stimmung und Carbidopa-Sicherheit.

St. John's Wort

Hyperizin, leichte Depression und CYP3A4-Wechselwirkungen.

Vagus Nerve Stimulation

Atmung, HRV, transkutane Stimulation und Anxiety.

L-Tryptophan

Serotonin/Melatonin, Aminosäuren-Konkurrenz und Outcomes.

SAMe (S-Adenosylmethionin)

Methylierung, Depression und Leberunterstützung.

Saffron (Crocin)

Depression-Studien, Stimmungsaufhellung und Augengesundheit.

EMDR / Trauma Therapy

PTSD, Augenbewegung und Studien-Wirksamkeit.

Sound Therapy / Binaural Beats

Frequenzen, Entspannung und Schlaf-Anwendungen.

Meditation / Mindfulness

MBSR, Telomere, Stress-Reduktion und Hirnstruktur-Effekte.

Cold Exposure (Mood)

Norepinephrin, Depression und Stimmungs-Effekte der Kälte.

FAQ

Frequently asked questions

When is self-optimization sensible and when do I need help?: Lifestyle and substance optimization fit mild to moderate mood swings, stress symptoms and exhaustion within normal life burden. Professional help is indicated for: symptoms over 2 weeks with significant impact on daily life, suicidal thoughts, hopelessness, severe sleep disorders despite hygiene, substance abuse, traumatic history, acute anxiety with panic attacks. Here no plant and no tracker is a substitute for a psychotherapist or psychiatrist.
Saffron — does it really work for mood?: Yes, with surprisingly solid evidence. Several meta-analyses (Lopresti, Hausenblas) show for saffron extract (30 mg/day, standardized to crocin and safranal) antidepressant effects comparable to low-dose SSRIs in mild to moderate depressive symptoms. Onset 6–8 weeks. Mechanism: serotonin and dopamine modulation, anti-inflammatory, antioxidative. Trade-offs: relatively expensive, mild gastric irritation possible. For severe symptoms: not an alternative to professional treatment.
SAMe (S-adenosylmethionine) — when is it sensible?: SAMe is a body-own methyl donor. Multiple RCTs show antidepressant effects at 400–1600 mg/day, onset faster than SSRIs (1–2 weeks). Particularly effective in subgroup with methylation issues (MTHFR polymorphisms). Trade-offs: expensive (40–80 €/month), frequent gastric irritation, can trigger manic episodes in bipolar disposition. Combination with SSRIs only under medical guidance due to serotonin syndrome risk.
Vagus nerve activation — what works evidence-based?: Breathing techniques are the most accessible vagus lever with the best evidence. Slow breathing (4–6 breaths/min, inhale 4 s, exhale 6–8 s) for 5–20 min measurably raises HRV and parasympathetic activity. Cold facial exposure (diving reflex) acutely dampens panic. Singing, humming, gargling also activate the vagus. Transcutaneous vagus stimulation (tVNS devices) has limited clinical data; in home settings evidence is thin. Meditation, yoga and HRV biofeedback all work via the same pathway.
5-HTP — for sleep and mood?: 5-HTP is a precursor to serotonin and can theoretically raise both pools. Studies on depression: smaller RCTs show effects comparable to SSRIs, but methodological weaknesses. Effect on sleep onset: documented at 100–300 mg before bed. Important cautions: serotonin syndrome with SSRIs, MAO inhibitors or triptans — separate strictly in time or avoid. Long-term dosing could alter amino acid balance; not longer than 3–6 months without break.
Meditation — how much per day makes a difference?: Robust meta-analysis (Pascoe et al., n=44 studies) shows: 20 min/day for 8 weeks reproducibly leads to reduced cortisol values (−25 %), lower subjective stress scores and better mood. Even 10 min/day has measurable effects when consistent. Form less crucial than consistency: mindfulness, loving-kindness, transcendental meditation have similar effects. A pure app-based solution (Calm, Headspace) is sufficient for beginners — a longer retreat or teacher accelerates the learning process.
St. John's Wort — hype or real substance?: For mild to moderate depressive symptoms several large meta-analyses with efficacy comparable to SSRIs (Cochrane review). Dose: 600–900 mg/day, standardized extract (e.g., WS 5570). Trade-offs are substantial: strong inducer of cytochrome-P450 enzymes — interacts with oral contraceptives (failure risk!), anticoagulants, immunosuppressants, antiretrovirals, many other drugs. With any concurrent medication: mandatory pharmacist or physician consultation. In severe cases no replacement for modern treatment.
EMDR and trauma therapy — where's the boundary to self-optimization?: EMDR (Eye Movement Desensitization and Reprocessing) is a trauma-specific psychotherapy method with strong evidence for PTSD and traumatic experiences. It belongs in the hands of qualified therapists — self-EMDR apps and YouTube tutorials are not recommended as evidence-based and can destabilize traumatized material. Anyone suspecting trauma history (childhood trauma, accidents, assaults) should take the step to therapy — no supplement resolves these themes.

More worlds